However, post-marketing surveillance and patient reports suggest that some individuals taking semaglutide do experience leg cramps during treatment
*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
learn nutrition and habit foundations Weeks 512: Dose adjustments
Counsel patients regarding the potential risk for MTC with the use of RYBELSUS or OZEMPIC tablets and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness)
Dispose of your used needles in a sharps container you can acquire one from your pharmacy
It depends on age, kidney function, medical history, and activity level